NCT03303339 2023-02-27Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)Cardiff OncologyPhase 1/2 Completed72 enrolled 31 charts